ArticleThe Annals of thoracic surgery2021

Should Neoadjuvant Therapy Be a Standard Modality for Patients With Clinical T2N0 Esophageal Cancer?

Wenjia Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.